What type of study is this?

This is a In Vitro Study study (also classified as: Observational).

September 5, 2025AntibioticsOpen Access

Hybrid 2-Quinolone–1,2,3-triazole Compounds: Rational Design, In Silico Optimization, Synthesis, Characterization, and Antibacterial Evaluation

View Full Paper

Ask AI

Bookmark

Authors

This research shows potent antibacterial effects of 2-quinolone–triazole compounds, suggesting new solutions for antibiotic resistance.

Potent antibacterial activity was observed against Gram-positive and Gram-negative strains, indicating strong drug potential.
Minimum inhibitory concentration (MIC) values ranged from 0.019 to 1.25 mg/mL, demonstrating effective antibacterial potency.
In silico optimization using QSAR modeling and molecular docking streamlined the design of effective antibacterial agents.
The study highlights the importance of developing new therapeutic compounds to address the growing challenge of antibiotic resistance.

El‐Mrabet et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

September 5, 2025AntibioticsOpen Access

View Full Paper

Ask AI

Bookmark

Authors

This research shows potent antibacterial effects of 2-quinolone–triazole compounds, suggesting new solutions for antibiotic resistance.

Potent antibacterial activity was observed against Gram-positive and Gram-negative strains, indicating strong drug potential.
Minimum inhibitory concentration (MIC) values ranged from 0.019 to 1.25 mg/mL, demonstrating effective antibacterial potency.
In silico optimization using QSAR modeling and molecular docking streamlined the design of effective antibacterial agents.
The study highlights the importance of developing new therapeutic compounds to address the growing challenge of antibiotic resistance.

El‐Mrabet et al. (2025) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark